Alaska Permanent Fund’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,924
Closed -$3.61M 415
2025
Q1
$3.61M Hold
11,924
0.05% 140
2024
Q4
$4.21M Hold
11,924
0.06% 122
2024
Q3
$4.27M Hold
11,924
0.06% 122
2024
Q2
$3.74M Buy
11,924
+3,752
+46% +$993K 0.06% 130
2024
Q1
$1.88M Buy
8,172
+5,921
+263% +$1.34M 0.03% 308
2023
Q4
$495K Sell
2,251
-1,079
-32% -$249K 0.01% 377
2023
Q3
$752K Buy
3,330
+57
+2% +$13.1K 0.01% 348
2023
Q2
$723K Buy
+3,273
New +$725K 0.01% 344
2022
Q4
$80K Buy
289
+57
+25% +$14.4K ﹤0.01% 350
2022
Q3
$49K Sell
232
-5
-2% -$1.12K ﹤0.01% 361
2022
Q2
$56K Sell
237
-14,443
-98% -$2.94M ﹤0.01% 358
2022
Q1
$2.63M Sell
14,680
-46
-0.3% -$8.76K 0.04% 105
2021
Q4
$2.97M Buy
14,726
+226
+2% +$44.4K 0.05% 55
2021
Q3
$2.68M Hold
14,500
0.05% 63
2021
Q2
$2.6M Sell
14,500
-7,000
-33% -$1.33M 0.05% 56
2021
Q1
$3.6M Hold
21,500
0.07% 97
2020
Q4
$3.26M Hold
21,500
0.06% 61
2020
Q3
$2.17M Buy
21,500
+10,060
+88% +$1.1M 0.03% 138
2020
Q2
$1.38M Hold
11,440
0.02% 35
2020
Q1
$1.08M Buy
+11,440
New +$1.09M 0.02% 39

Other funds holding UTHR

Alaska Permanent Fund's UTHR Position: Q2 2025 in Review

Alaska Permanent Fund sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 11,924 shares — an estimated $3.61M sold.

Alaska Permanent Fund first reported a position in UTHR in Q1 2020 and held it in 20 quarters. The position peaked at $4.27M in Q3 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Alaska Permanent Fund reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 11,924 United Therapeutics shares in Q2 2025, an estimated $3.61M.
  • Alaska Permanent Fund first reported a position in United Therapeutics in Q1 2020 and held it in 20 quarters.
  • Alaska Permanent Fund's United Therapeutics position peaked at $4.27M in Q3 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.